Keyphrases
Tumor-immune System
53%
Lung Adenocarcinoma
50%
Immune Evolution
50%
Myeloma
50%
Molecular Heterogeneity
50%
Single-cell Profiling
50%
Mantle Cell Lymphoma
50%
Tumor Cells
42%
T Cells
39%
Tumor Immune Microenvironment
30%
Primary Resistance
29%
Immunotherapy Resistance
29%
Immune Checkpoint Therapy
29%
Immune Cells
25%
Acknowledgment
25%
Heterozygosity
25%
Tumor Immunity
25%
Precursor Disease
25%
Immunogenomic Landscape
25%
B Cells
25%
Cellular Stress Response
25%
Fetal Fraction
25%
Cell Infusion
25%
Lymphoma Microenvironment
25%
MHC Class II Expression
25%
Lineage Diversity
25%
Metastatic Gastric Adenocarcinoma
25%
Pan-cancer
25%
Plasma Cells
25%
Transcriptome Evolution
25%
Cell Atlas
25%
Liver Kinase B1 (LKB1)
25%
Response States
25%
Lactate Secretion
25%
Large B-cell Lymphoma
25%
Cold Tumor
25%
Follicular Lymphoma
25%
Monocarboxylate Transporter 4 (MCT4)
25%
Noninvasive Prenatal Screening
25%
Cell mutation
25%
Compound Probiotics
25%
9p21
25%
Specific Intent
25%
Anti-CD19 chimeric Antigen Receptor T Cells
25%
Intratumoral Heterogeneity
25%
Multiple Myeloma
25%
Mutation Classes
25%
Early-stage Lung Adenocarcinoma
25%
NIH Funding
25%
Bioinformatics Analysis
25%
Medicine and Dentistry
Immunity
100%
Immunotherapy
75%
Malignant Neoplasm
66%
Tumor Microenvironment
50%
Stomach Adenocarcinoma
50%
Myeloma
50%
Neoplasm
49%
Progression Free Survival
31%
Disease Exacerbation
30%
Cell Line
28%
Infusion
25%
Genetic Screening
25%
Melanoma
25%
Stromal Cell
25%
Chimeric Antigen Receptor T-Cell
25%
Immune Checkpoint Blockade
25%
T Cell
25%
Precursor
25%
Diseases
25%
Gut Microbiome
25%
Probiotics
25%
Multiple Myeloma
25%
Large-Cell Lymphoma
25%
Triggering Receptor Expressed on Myeloid Cells 2
25%
Cellular Stress Response
25%
Ovarian Cancer
25%
Pembrolizumab
25%
Mantle Cell Lymphoma
25%
Ferroptosis
25%
Abdominal Cancer
25%
Isocitrate Dehydrogenase
25%
Ganglioglioma
25%
Cytotoxic T-Cell
22%
Metastatic Carcinoma
19%
Granisetron
16%
Zonisamide
16%
Overall Survival
15%
Cancer Cell
14%
Chimeric Antigen Receptor T-Cell Immunotherapy
13%
Transcriptomics
13%
Biological Marker
13%
Toxicity and Intoxication
12%
Axicabtagene Ciloleucel
12%
Effector Cell
12%
Immunocompetent Cell
12%
RNA Sequence
11%
Microglia
10%
Programmed Death-Ligand 1
10%
Cancer Associated Fibroblast
10%
Krukenberg Tumor
10%
Immunology and Microbiology
Immunotherapy
83%
Immunity
76%
T Cell
75%
Tumor Cell
60%
Immunocompetent Cell
59%
Lineage
50%
Cell Population
50%
Lymphoma Cell
41%
Transcriptomics
37%
Immunoglobulin Producing Cell
33%
B Cell
33%
Cytotoxic T-Cell
25%
Multiple Myeloma
25%
M2 Macrophages
25%
Microglia
25%
Precursor
25%
Secretion (Process)
25%
Ferroptosis
25%
Ecotype
25%
Immune Landscape
25%
Single-Cell Sequencing
25%
MHC Class II
25%
Cellular Stress Response
25%
B-Cell Receptor
21%
Macrophage
20%
Regulatory T Cell
20%
RNA Sequence
20%
Cancer Cell
20%
CXCL13
16%
Cell Lineage
16%
Cancer Associated Fibroblast
16%
Transcriptome
16%
Dynamics
15%
Syngenic
12%
Murine
12%
Dendritic Cell
12%
Cell Heterogeneity
12%
T Lymphocyte Antigen
12%
Lymphocyte
11%
CD4
11%
Chimeric Antigen Receptor T-Cell Therapy
10%
Immunosuppressive Drug
8%
Immunoglobulin A
8%
Antigen-Presenting Cell
8%
Genetic Difference
8%
Wild Type
8%
T Cell Subset
8%
T-Helper Cell
8%
Myeloid
8%
Granulysin
8%